杭州打造生物样本库 加速生物医学前沿技术临床转化

Core Viewpoint - The establishment of the Hangzhou Biobank aims to create an international-level resource-sharing service hub for biological samples, promoting a deep integration of government, industry, academia, research, and application in the biomedicine sector [1]. Group 1: Biobank Establishment - The biobank was initiated in 2020 and features a "2+3+4" operational structure, which includes dual leadership from the Hangzhou Health Commission and Qiantang District, along with three committees for management, scientific technology, and regional ethics, and four centers for preservation, information, transformation, and operation [3]. - The biobank has attracted over 80 partner organizations, including leading institutions such as the Beijing Biobank, West Lake University, Liangzhu Laboratory, and East China Pharmaceutical, aiming to connect clinical research with industrial transformation [3]. Group 2: Collaborative Projects - During the signing ceremony, partnerships were established with eight units, covering projects in areas such as early cancer screening, depression treatment, and amyotrophic lateral sclerosis research [3]. - The biobank will serve as a bridge in the "basic research - clinical validation - industrial transformation" process, showcasing projects like "AI and omics-enabled next-generation biobanks" and "gene multi-omics plan for skin diseases" [4]. Group 3: Future Development - The biobank plans to focus on standardized construction to create a comprehensive biological sample resource network throughout its lifecycle, accelerating clinical transformation of cutting-edge technologies like gene testing and cell therapy through deep collaboration with universities and enterprises [4]. - As the medical-enterprise integration ecosystem improves, Hangzhou is expected to establish a virtuous cycle in biomedicine characterized by "data-driven research, research leading industry, and industry serving health" [4].